Navigation Links
Molecular Devices Introduces the FLIPR Penta System
Date:8/1/2019

Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System.

The new FLIPR Penta system builds on the success of the industry-leading FLIPR® platform for monitoring of G-protein-coupled receptors (GPCRs) and ion channels, offering a new high-speed camera option capable of capturing key dynamics of induced pluripotent stem cell (iPSC)-derived neuronal and cardiac cells at higher frame resolution. Additionally, the new ScreenWorks® Peak Pro 2 software adds capabilities to translate these higher resolution signals into key insights, adding over 30 new measurements to the analysis package.

"The expanded capabilities of the FLIPR Penta System will allow scientists studying stem cell-derived neuronal and cardiac cells to better characterize physiologic effects of compounds,” explains Sarah Vargas-Hurlston, Sr. Director of Product Marketing at Molecular Devices. “This new product builds on our established track record of providing complete high throughput screening solutions by adding capabilities to support drug discovery and early safety evaluation using new iPSC-based models."

For more information, visit http://www.moleculardevices.com.

Read the full story at https://www.prweb.com/releases/molecular_devices_introduces_the_flipr_penta_system/prweb16471745.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Molecular Diagnostics Market: 5 Things You Need to Know
2. Molecular Devices Announces the Appointment of Susan Murphy as President
3. Molecular Devices Features FLIPR 1536-well Application in High-throughput Screening in Educational Webinar
4. Molecular Diagnostics - Global Market Size, Strategy and Forecasts - 2015 to 2019
5. Report: Hologic, Abbott, Roche and Qiagen Lead Molecular Testing
6. Researchers uncover new evidence revealing molecular paths to autism
7. Elsevier announces launch of open journal: Biomolecular Detection and Quantification
8. Study examines type of exome sequencing and molecular diagnostic yield
9. Molecular probes permit doctors to detect diabetic retinopathy before vision fails
10. MARC travel awards announced for GSA: Mouse Molecular Genetics Conference
11. Kalorama Report: Sizable Number of Acquisitions and Joint Ventures in Molecular Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2019)... ... 2019 , ... In October, Massachusetts stem cell biotechnology company ... a poorly disclosed deficiency in stem cell treatments. Throughout stem cell medical ... stem cells. This problem affects all patients receiving stem cell treatments, including ...
(Date:11/5/2019)... WA (PRWEB) , ... November 05, 2019 , ... ... & Amato Dentistry, providing state-of-the-art cosmetic and restorative dentistry to Seattle, WA, including ... her Doctor of Dental Surgery degree from the University of Washington, Dr. Kopp ...
(Date:10/30/2019)... ... October 29, 2019 , ... LGC Maine Standards ... analyzers, Order Numbers 701sa & 704sa. The kits, in a human-urine matrix, evaluate ... , Each VALIDATE® kit, liquid, ready-to-use, and prepared using the CLSI EP06-A “equal ...
Breaking Biology News(10 mins):
(Date:10/30/2019)... ... 2019 , ... Western University of Health Sciences held Innovation ... in educating the next generation of health care providers. , The event, organized ... administrators and representatives of companies working with the University on a range of ...
(Date:10/26/2019)... PHILADELPHIA (PRWEB) , ... October 24, 2019 , ... ... its investment in Bichsel Medical Marketing Group (BMMG), a boutique healthcare-specific ... enhance the offerings of its in-house Healthcare Strategy Division. , Healthcare clients in ...
(Date:10/22/2019)... , ... October 22, 2019 , ... ... has announced that its lead program, DBI-001, met its primary safety endpoints, with ... labeled phase 2a clinical trial for the treatment of interdigital tinea pedis (athlete’s ...
(Date:10/10/2019)... ... October 09, 2019 , ... ... MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the ... in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative medicine ...
Breaking Biology Technology: